International reference: 2 US FDA recalls for this ingredient

Lack of sterility assurance. (glycyrrhizic)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance (glycyrrhizic)

US-market enforcement records (OpenFDA), shown for reference - not specific to this product in Ghana.

Valid Ghana · FDA Ghana

CG-HERBS ORAL SOLUTION

Glycyrrhizic acid

FDA/V.255-05068 Glycyrrhizic acid 165mg

What it does

Glycyrrhizic is a natural compound derived from licorice root, commonly used for its soothing properties.

Commonly used for: sore throat, inflammation, gastric ulcers

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/V.255-05068
Registration date
2025-05-19
Expiry date
2030-05-01
Status
Valid
Active ingredient
Glycyrrhizic acid
Dosage form
Glycyrrhizic acid
Strength
165mg
Pack size
-
Therapeutic class
-
RxNorm RxCUI
1370586
Manufacturer / MAH
Aether Centre Biology
Country of origin
CHINA

Source: Food and Drugs Authority · fetched 2026-04-18 08:32:59 · updated 2026-10-20 04:00:14

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Glycyrrhizic is a natural compound derived from licorice root, commonly used for its soothing properties.

What it treats

  • sore throat
  • inflammation
  • gastric ulcers

How it works

Glycyrrhizic helps reduce inflammation and soothe irritation in the body.

Who it's for

It is suitable for adults and children, but should be used with caution in certain health conditions.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: glycyrrhizic

Glycyrrhizic acid, derived from the root of Glycyrrhiza glabra (licorice), is a triterpenoid saponin known for its anti-inflammatory, antiviral, and hepatoprotective properties. It is commonly used in traditional medicine and has gained interest in modern pharmacology for its potential therapeutic applications.

Indications

  • Adrenal insufficiency
  • Chronic inflammatory conditions
  • Hepatitis
  • Cirrhosis
  • Adverse effects of corticosteroids

Dosage

Children: Refer to the BNF for Children for appropriate dosing based on age and weight.

Adults: Dosage varies based on the condition being treated. Refer to specific guidelines or the BNF for appropriate dosing.

Mechanism of action

Glycyrrhizic acid inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), which converts active cortisol to its inactive form cortisone. By inhibiting this enzyme, glycyrrhizic acid increases the levels of active cortisol, leading to enhanced glucocorticoid activity. It also exhibits anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines and modulating the immune response.

Pharmacodynamics

Glycyrrhizic acid demonstrates a range of pharmacodynamic effects, including anti-inflammatory, immunomodulatory, and antioxidant activities. It has been shown to reduce inflammation by inhibiting the nuclear factor kappa B (NF-κB) signaling pathway, leading to decreased expression of inflammatory mediators. Additionally, glycyrrhizic acid has potential benefits in liver protection and regulation of the hypothalamic-pituitary-adrenal (HPA) axis.

Pharmacokinetics

Following oral administration, glycyrrhizic acid is absorbed in the gastrointestinal tract and undergoes extensive metabolism, primarily in the liver. It has a bioavailability that can vary depending on dosage form and individual metabolism. Glycyrrhizic acid is known to have a long half-life, and its metabolites may have biological activity. Excretion occurs mainly through urine, with both unchanged glycyrrhizic acid and its metabolites being eliminated.

Contra-indications

  • Hypersensitivity to glycyrrhizic acid or any component of the formulation
  • Severe liver disease
  • Hypertension
  • Hypokalemia
  • Corticosteroid therapy

Adverse effects

  • Hypertension
  • Hypokalemia
  • Edema
  • Headache
  • Fatigue
  • Muscle weakness
  • Cardiac arrhythmias
  • Gastrointestinal disturbances

Interactions

  • Corticosteroids - may enhance the effects and side effects of corticosteroids
  • Diuretics - may increase the risk of hypokalemia
  • Digoxin - may enhance the effects of digoxin leading to toxicity
  • Antihypertensives - may reduce the effectiveness of antihypertensive medications

Precautions

  • Use with caution in patients with a history of hypertension
  • Monitor blood pressure and potassium levels during prolonged use
  • Consider potential interactions with other medications
  • Use with caution in patients with a history of cardiac disease

Pregnancy

There is insufficient evidence on the safety of glycyrrhizic during pregnancy. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised as glycyrrhizic may be excreted in breast milk. Consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Oral tablets
  • Syrups
  • Powders for reconstitution
  • Topical preparations

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.